Evidence map›Paper›PMID 41882579›Full record

ArticleBMC neurology2026

Posterior reversible encephalopathy syndrome in the setting of severe systemic lupus erythematosus activity with a rapidly fatal outcome: a case report.

Yun Shen, Jing Wang, Zheng Han, Wei Shi, Xue-Lian Wang, Bao Wang

Abstract readCase Reports
In one paragraph

Article in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yun Shen *Department of Neurosurgery, Tangdu Hospital, Air Force Medical University, Xi'an, Shaanxi province, 710038, China.
Jing Wang *Department of Neurosurgery, Tangdu Hospital, Air Force Medical University, Xi'an, Shaanxi province, 710038, China.
Zheng Han *Department of Neurosurgery, Tangdu Hospital, Air Force Medical University, Xi'an, Shaanxi province, 710038, China.
Wei ShiDepartment of Neurosurgery, PLA 960 th hospital, JiNan, ShanDong province, 250031, China.
Xue-Lian WangDepartment of Neurosurgery, Tangdu Hospital, Air Force Medical University, Xi'an, Shaanxi province, 710038, China. wangxlbrain@163.com.
Bao WangDepartment of Neurosurgery, Tangdu Hospital, Air Force Medical University, Xi'an, Shaanxi province, 710038, China. bob.kane@163.com.

Funding

National Natural Science Foundation of China 81801256Natural Science Foundation of Tibet Autonomous Region XZ202501ZR0086Tangdu Hospital Youth Talent supporting Plan 2023ATDQN004
6 · The paper itself

Abstract

backgroundPosterior reversible encephalopathy syndrome (PRES) is typically considered a self-limiting neurological disorder with a favorable prognosis when promptly diagnosed and treated. However, we report a rare fulminant case of PRES in a patient with systemic lupus erythematosus (SLE), challenging the notion of its uniformly benign course. CASE PRESENTATION: A 50-year-old Asian woman with a recent diagnosis of active SLE and dialysis-dependent renal failure presented with an 8-hour history of headache, dizziness, visual impairment, and seizures. Brain MRI revealed bilateral parieto-occipital lesions consistent with PRES. Diffusion-weighted imaging (DWI) showed mixed hyperintensity corresponding to low signal on the apparent diffusion coefficient (ADC) map, confirming true diffusion restriction and indicating cytotoxic edema. Despite immediate admission to the neurological intensive care unit and administration of corticosteroids, antihypertensives, and antiepileptics, the patient experienced rapid neurological deterioration. Within 70 min, she developed massive oral and nasal bleeding, followed by cardiac arrest and death. Laboratory tests showed moderate thrombocytopenia, but no platelet transfusion was administered per current guidelines due to the absence of active bleeding at the time of admission.

conclusionsThis case highlights a fulminant and multifactorial clinical course of severe systemic lupus erythematosus, in which PRES represented a secondary neurological manifestation rather than the primary cause of death. It underscores the importance of recognizing PRES in patients with active SLE as a marker of severe systemic disease activity and emphasizes the need for prompt multidisciplinary evaluation and comprehensive management of underlying systemic involvement.

Indexed as

Lupus Erythematosus, SystemicPosterior Leukoencephalopathy SyndromeBrainFatal OutcomeFemaleHumansMiddle AgedFatal outcomePosterior reversible encephalopathy syndromeRapid progressionRenal failureSystemic lupus erythematosusThrombocytopenia

Identifiers

PMID41882579
PMCPMC13141255

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.